- ISIN DE000A3MQR65
- Country Deutschland
Viromed Medical AG
Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected
|
Viromed Medical AG / Key word(s): Alliance Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® by Viromed – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected from 2025 onwards Uwe Perbandt End of Inside Information
22-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Viromed Medical AG |
| Flensburger Straße 18 | |
| 25421 Pinneberg | |
| Germany | |
| Phone: | +49 4101 809960 |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg |
| EQS News ID: | 1886029 |
| End of Announcement | EQS News Service |